Results 71 to 80 of about 17,743 (275)

Prolonged response to pemetrexed-based chemotherapy in a patient with peritoneal mesothelioma: a case report and review of the literature

open access: yesPteridines, 2016
Peritoneal mesothelioma is a rare tumor typically presenting with ascites and associated with occupational asbestos exposure with a latency period of 20–40 years.
Študentová Hana   +4 more
doaj   +1 more source

Risk factors of mortality from all asbestos-related diseases: A competing risk analysis. [PDF]

open access: yes, 2018
Background. The mortality from all malignant and nonmalignant asbestos-related diseases remains unknown. The authors assessed the incidence and risk factors for all asbestos-related deaths. Methods.
Abós-Herràndiz, Rafael   +10 more
core   +1 more source

Immunohistochemical characterization of peritoneal inclusion cysts with squamous metaplasia

open access: yesHistopathology, Volume 88, Issue 2, Page 533-537, January 2026.
Aims Peritoneal inclusion cysts (PICs) are mesothelial‐lined cysts that can uncommonly develop squamous metaplasia. Here, we describe the immunophenotype of PICs with squamous metaplasia using a comprehensive immunohistochemical (IHC) panel. Methods and results We collected surgical excisions of PICs with squamous metaplasia from our institution and ...
Heather I Chen‐Yost   +6 more
wiley   +1 more source

Case of Peritoneal Malignant Mesothelioma in a 60-year-old Lady Presenting Clinically With Huge Abdominopelvic Mass: A Diagnostic Challenge [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Peritoneal malignant mesothelioma is a rare tumour that poses diagnostic challenges due to vague clinical symptoms, a variable histologic picture and being a common site for metastasis from GI organ, ovary, kidney and several other organs. We presented a
Usha Sarma   +2 more
doaj   +1 more source

Benign peritoneal cystic mesothelioma mimicking peritoneal tuberculosis

open access: yesClinical Case Reports, 2022
In immunodeficient patients with repetitive peritoneal aggression, cystic mesothelioma should be considered as a differential diagnosis to peritoneal tuberculosis that must be ruled out in endemic countries.
Chayma Soltani   +2 more
doaj   +1 more source

Protein Tyrosine Phosphatase 4A1 (PTP4A1) Regulates Early Events in Colorectal Cancer Intraperitoneal Dissemination in the Aged Male Host

open access: yesAging and Cancer, Volume 6, Issue 4, Page 93-105, December 2025.
Colorectal cancer (CRC) mortality is highest in aged males. Pre‐clinical data comparing CRC i.p. metastasis in cohorts of young and aged, male and female mice support these finding. Bottom‐up proteomics of peritoneal mesothelial cells identified PTP4A1 as highly expressed in aged males and a role for PTP4A1 in heterotypic cell:cell adhesion was ...
Zhikun Wang   +17 more
wiley   +1 more source

Mesotelioma peritoneal maligno.

open access: yesActa Médica Portuguesa, 2011
Malignant peritoneal mesothelioma is a rare tumor arising from the mesothelial cells of this serosal membrane. The authors report a case of a female patient referred to our hospital for ascites of unknown etiology.
Cláudia Cardoso   +3 more
doaj   +1 more source

Multiscale Construction, Evaluation, and Application of Organoids

open access: yesAdvanced Science, Volume 12, Issue 47, December 18, 2025.
Organoids are pivotal models with transformative biomedical potential. A comprehensive multi‐scale perspective is presented, encompassing dual‐scale construction, four‐dimensional evaluation, triple‐point application, and an analysis of the current challenges faced by organoid technology, aiming to advance organoid research and its biomedical ...
Wanting Ma   +5 more
wiley   +1 more source

Malignant mesothelioma in rare sites: two case reports

open access: yesFrontiers in Oncology
Mesothelioma is a rare tumor originating from mesothelial cells in the pleura or other sites. Malignant pleural mesothelioma (MPM) is the most common aggressive type of mesothelioma (accounting for 81%) and carries a poor prognosis (median OS: 1 year ...
Qiguang Du   +7 more
doaj   +1 more source

CONFIRM: a double-blind, placebo controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial [PDF]

open access: yes, 2018
Background: Mesothelioma is an incurable, apoptosis-resistant cancer caused in most cases by previous exposure to asbestos and is increasing in incidence.
AS Mansfield   +31 more
core   +4 more sources

Home - About - Disclaimer - Privacy